510(k) Report

510(k) · Cleared

Recalled · Class II · 2012

Model IR 1200 Insulin Pump

K032257510(k) TraditionalCleared Oct 16, 200386-day reviewClass II21 CFR 880.5725Recalls 7

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Animas Corp. · LZG Pump, Infusion, Insulin

Cleared on Oct 16, 2003 after an 86-day review. The FDA summary names its predicate without a number. 1 of the 44 devices in its family, counting itself, has a Class I recall. 43 later devices descend from it. It has been recalled 7 times.

Decided
Oct 16, 2003
Review
86 days
Class
Class II
Product code
LZG
Recalls
7
Predicates
0

43 later devices descend from it, 2 citing it directly. 1 of the 44 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2011: 1 descendant cleared2005: 1 descendant cleared2006: 1 descendant cleared2013: 3 descendants cleared2012: 1 descendant cleared2014: 2 descendants cleared2015: 2 descendants cleared2016: 2 descendants cleared2023: 4 descendants cleared2022: 2 descendants cleared2018: 2 descendants cleared2020: 5 descendants cleared, 1 with a Class I recall12017: 2 descendants cleared2025: 5 descendants cleared2024: 3 descendants cleared2021: 2 descendants cleared2026: 5 descendants cleared200020052010201520202025
  1. This deviceK032257 Model IR 1200 Insulin PumpAnimas Corp. · 2003
  2. Descendant · cites it directly · 39 of its ownK042887 Accu-Chek SpiritDisetronic Medical Systems AG · 2005 · Recalled
  3. Descendant · 2 generations on · 38 of its ownK060876 Accu-Chek Insulin Pump Configuration Software (Standard), Model…Disetronic Medical Systems AG · 2006 · Recalled
  4. Descendant · 3 generations on · 37 of its ownK111353 Accu-Check Combo SystemRoche Diagnostics · 2012 · Recalled
  5. Descendant · 4 generations on · 33 of its ownK141929 Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · Recalled
  6. Descendant · 5 generations on · 32 of its ownK150910 ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · Recalled

Showing 5 of 43 descendants. See all descendants

Descendants cleared per year

2005: 12006: 12011: 12012: 12013: 32014: 22015: 22016: 22017: 22018: 22020: 52021: 22022: 22023: 42024: 32025: 52026: 5
2005high 5 (2020) · low 0 (2007)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 43 · See all
  • K042887Accu-Chek SpiritDisetronic Medical Systems AG · 2005 · cites it directly39descendants
  • K060876Accu-Chek Insulin Pump Configuration Software (Standard), Model 04625137001; Accu-Chek…Disetronic Medical Systems AG · 2006 · 2 generations on38descendants
  • K111353Accu-Check Combo SystemRoche Diagnostics · 2012 · 3 generations on37descendants
  • K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation · 2015 · 4 generations on33descendants
  • K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc. · 2015 · 5 generations on32descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K032257Model IR 1200 Insulin PumpAnimas Corp.2003—
+1K042887Accu-Chek SpiritDisetronic Medical Systems AG20051
+2K060876Accu-Chek Insulin Pump Configuration Software (Standard), Model 04625137001…Disetronic Medical Systems AG20061
+3K111353Accu-Check Combo SystemRoche Diagnostics20123
+4K141929Accu-Chek Connect Diabetes Management AppRoche Diagnostics Corporation20151
+5K150910ACCU-CHEK Connect Diabetes Management AppRoche Diabetes Care, Inc.20156

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200610
201110
201210
201330
201420
201520
201620
201720
201820
202051
202120
202220
202340
202430
202550
202650
FIG. 1 — Lineage of K032257, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZG device

  1. #1 K253534 Pivot Insulin Delivery Systemscore 16.9 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Animas IR 1000 Series Insulin Infusion Pump
Named without a submission number
—

What descends from it? (43)

See all 43

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042887Accu-Chek SpiritDisetronic Medical Systems AG200539
K100567Pearl Diabetes Management SystemM2 Group Holdings, Inc.20112

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 17, 2012Class IIIZ-0836-2013Device DesignDue to an internal calendar date limit (December 31, 2015) these pumps will cease to operate on January 1, 2016, and will result in a call service alarm that is displayed on the pump display.
Jul 16, 2012Class IIZ-0005-2013Nonconforming Material/ComponentWear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump.
Feb 25, 2011Not classifiedZ-1678-2011Material/Component ContaminationAction is being undertaken to address the occurrence of adverse events associated with leaking cartridges. Firm became aware of this issue through customer complaints from pump users reporting the cartridges were leaking.
Mar 18, 2010Not classifiedZ-2396-2010Equipment maintenancesensor could be damaged
Aug 4, 2008Not classifiedZ-0293-2009Nonconforming Material/ComponentUnintentional rebooting: Pump products exhibit an intermittent loss of power due intermittent loss of contact between battery cap and battery canister resulting in the device resetting. The failure of the battery cap may result in failure…
Oct 31, 2005Not classifiedZ-0308-06OtherPumps were refurbished more than one time for the same failure mode in violation of the company's procedure.
Sep 28, 2004Not classifiedZ-0211-05OtherSuspend mode not functioning properly

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K193483Basal-IQ TechnologyTandem Diabetes Care, Inc. · 2020 · 8 generations on · ◆ in the 2020 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K042887 (Disetronic Medical Systems AG, 2005) has gone furthest, with 39 descendants of its own.

How does its category compare?

All LZG devices

LZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZG

2in 2024

2007: 32008: 62009: 22010: 22011: 42012: 32013: 22014: 42015: 12016: 42017: 12018: 12019: 22021: 12022: 12023: 12024: 22026 (partial year): 2
2007high 6 (2008) · low 0 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZG

116in 2016

2007: 112 days median2008: 129 days median2011: 189 days median2012: 73 days median2014: 123 days median2016: 116 days median
2007high 189 (2011) · low 73 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZG

1in 2022

2007: 12008: 132009: 22010: 42011: 22012: 42013: 3, 1 Class I2014: 2, 1 Class I2015: 2, 2 Class I2018: 3, 2 Class I2019: 52022: 1, 1 Class I2026 (partial year): 2, 2 Class I
2007high 13 (2008) · low 0 (2016)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · LZG

12,004in 2025

2007: 5,1102008: 5,7112009: 9,4712010: 10,1752011: 12,8582012: 18,3672013: 30,0592014: 49,1882015: 69,1362016: 56,5812017: 44,4722018: 32,6522019: 29,0272020: 32,5882021: 31,5222022: 28,2252023: 21,9722024: 18,2282025: 12,004
2007high 69,136 (2015) · low 5,110 (2007)2025

MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311215,110
20086129135,711
20092—29,471
20102—410,175
20114189212,858
2012373418,367
20132—3 (1)30,059
201441232 (1)49,188
20151—2 (2)69,136
20164116056,581
20171—044,472
20181—3 (2)32,652
20192—529,027
20200—032,588
20211—031,522
20221—1 (1)28,225
20231—021,972
20242—018,228
20250—012,004
20262—2 (2)—

What is it indicated for?

The Animas Model Model IR 1200 Insulin Infusion Pump is intended to provide subcutaneous delivery of insulin at programmable basal and bolus rates for the daily management of diabetes mellitus in insulin dependent patients.

This device is intended for home use and is a prescription device.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K032257: Model IR 1200 Insulin Pump.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K032257

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026